A study found that a risk calculator had no significant impact on surgeons’ decisions regarding surveillance for low-risk pancreatic intraductal papillary mucinous neoplasms (IPMNs).
- Clinicians’ estimated likelihood of progression remained unchanged (88% vs. 89% for vignettes).
- Recommendation to continue surveillance did not significantly differ (57% vs. 41% across scenarios).
Surgeons reported varying cancer risk thresholds, indicating a lack of consensus.
- Future research is needed to understand why risk calculators are ineffective in altering decision-making.
Journal Article by Sacks GD, Korfage IJ (…) Gonda TA et 2 al. in Ann Surg Oncol
© 2026. Society of Surgical Oncology.